ArticleMolecular medicine (Cambridge, Mass.)2026

LARS promotes hepatocellular carcinoma progression via the PI3K/AKT/mTOR pathway and interaction with RPS5, and serves as a prognostic biomarker.

Hanbin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.